Effects of adrenal dysfunction and high-dose adrenocorticotropic hormone on NMDA-induced spasm seizures in young Wistar rats

Epilepsy Research

Volumn 100, Issue 1-2, 2012, Pages 125-131

  Wang, Ya Jie ^a,b   Zhang, Ying ^a,c   Liang, Xian Hong ^b   Yang, Guang ^a   Zou, Li Ping ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c QINGDAO UNIVERSITY   (China)

Author keywords

Adrenalectomy; Adrenocorticotropic hormone (ACTH); Corticotrophin releasing hormone (CRH); Hippocampus; Infantile spasms; N Methyl d aspartate (NMDA)

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; MESSENGER RNA;

ADRENAL DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MEGADOSE; GENE OVEREXPRESSION; HIPPOCAMPUS; HORMONE RELEASE; INFANTILE SPASM; LATENT PERIOD; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE;

ADRENAL GLAND DISEASES; ADRENALECTOMY; ADRENOCORTICOTROPIC HORMONE; AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; N-METHYLASPARTATE; RATS; RATS, WISTAR; SEIZURES; SPASM;

EID: 84861528551     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2012.02.001     Document Type: Article

References (32)

1. Aicardi J. Infant spasms and related syndromes. Epilepsy in Children 1986, 17-38. Raven Press Ltd, New York. J. Aicardi (Ed.).
2. Baram T.Z. Pathophysiology of massive infantile spasms: perspective on the putative role of the brain adrenal axis. Ann. Neurol. 1993, 33:231-236.
3. Baram T.Z., Mitchell W.G., Tournay A., et al. High-dose corticotropin versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics 1996, 97:375-379.
4. Berg A.T., Shinnar S., Shapiro E.D., Salomon M.E., Crain E.F., Hauser W.A. Risk factors for a first febrile seizure: a matched case-control study. Epilepsia 1995, 36:334-341.
5. Brunson K.L., Khan N., Eghbal-Ahmadi M., Baram T.Z. Corticotropin (ACTH) acts directly on amygdala neurons to down-regulate corticotropin-releasing hormone gene expression. Ann. Neurol. 2001, 49:304-312.
6. Chachua T., Yum M.S., Velíšková J., Velíšek L. Validation of the rat model of cryptogenic infantile spasms. Epilepsia 2011, 52(9):1666-1677.
7. Chen Y., Brunson K.L., Adelmann G., Bender R.A., Frotscher M., Baram T.Z. Hippocampal corticotropin-releasing hormone: pre- and postsynaptic location and release by stress. Neuroscience 2004, 126:533-540.
8. Hollrigel G.S., Chen K., Baram T.Z., Soltesz I. The pro-convulsant actions of corticotropin-releasing hormone in the hippocampus of infant rats. Neuroscience 1998, 84:71-79.
9. Holmes G.L. Epilepsy in the developing brain: lessons from the laboratory and clinic. Epilepsia 1997, 38(1):12-30.
10. Jacobson L., Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenal axis. Endocr. Rev. 1991, 12:118-134.
11. Johnston M.V. Developmental aspects of epileptogenesis. Epilepsia 1996, 37(Suppl. 1):S2-S9.
12. Kábová R., Liptáková S., Slamberová R., Pometlová M., Velísek L. Age-specific N-methyl-d-aspartate-induced seizures: perspectives for the West syndrome model. Epilepsia 1999, 40:1357-1369.
13. King B.R., Smith R., Nicholson R.C. Novel glucocorticoid and cAMP interactions on the CRH gene promoter. Mol. Cell. Endocrinol. 2002, 194:19-28.
14. Lux A.L., Edwards S.W., Hancock E., et al. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol. 2005, 4:712-717.
15. Mares P., Velísek L. N-methyl-d-aspartate (NMDA)-induced seizures in developing rats. Brain Res. Dev. Brain Res. 1992, 65(2):185-189.
16. Ma X.M., Camacho C., Aguilera G. Regulation of corticotropin-releasing hormone (CRH) transcription and CRH mRNA stability by glucocorticoids. Cell. Mol. Neurobiol. 2001, 21:465-475.
17. Mountjoy K.G., Mortrud M.T., Low M.J., Simerly R.B., Cone R.D. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol. 1994, 8:1293-1308.
18. Rakhade S.N., Jensen F.E. Epileptogenesis in the immature brain: emerging mechanisms. Nat. Rev. Neurol. 2009, 5(7):380-391.
19. Rubin L.L., Staddon J.M. The cell biology of the blood-brain barrier. Annu. Rev. Neurosci. 1999, 22:11-28.
20. Shang N.X., Zou L.P., Zhao J.B., Zhang F., Li H. Association between prenatal stress and infantile spasms: a case-control study in China. Pediatr. Neurol. 2009, 42:181-186.
21. Smith M.A., Weiss S.R., Berry R.L., et al. Amygdala-kindled seizures increase the expression of corticotropin-releasing factor (CRF) and CRF-binding protein in GABAergic interneurons of the dentate hilus. Brain Res. 1997, 745(1-2):248-256.
22. Stafstrom C.E., Sasaki-Adams D.M. NMDA-induced seizures in developing rats cause long-term learning impairment and increased seizure susceptibility. Epilepsy Res. 2003, 53(1-2):129-137.
23. Suda T., Yajima F., Tomori N., et al. Inhibitory effect of adrencorticotropin on corticotropin-releasing factor release from rat hypothalamus in vitro. Endocrinology 1986, 118:459-461.
24. Twardowska K., Rybakowski J. Limbic-hypothalamic-pituitary-adrenal axis in depression. Psychiatr. Pol. 1996, 30:741-756.
25. Van Pett K., Viau V., Bittencourt J.C., et al. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 2000, 428:191-212.
26. Velísek L., Jehle K., Asche S., Velísková J. Model of infantile spasms induced by N-methyl-d-aspartic acid in prenatally impaired brain. Ann. Neurol. 2007, 61(2):109-119.
27. Wang W., Murphy B., Dow K.E., David Andrew R., Fraser D.D. Systemic adrenocorticotropic hormone administration down-regulates the expression of corticotropin-releasing hormone (CRH) and CRH-binding protein in infant rat hippocampus. Pediatr. Res. 2004, 55:604-610.
28. Watson S.J., Richard C.W., Barchas J.D. Adrenocorticotropin in rat brain: immunocytochemical localization in cells and axons. Science 1978, 200:1180-1182.
29. Watzka M., Beyenburg S., Blümcke I., Elger C.E., Bidlingmaier F., Stoffel-Wagner B. Expression of mineralocorticoid and glucocorticoid receptor mRNA in the human hippocampus. Neurosci. Lett. 2000, 290:121-124.
30. Yan X.X., Toth Z., Schultz L., Ribak C.E., Baram T.Z. Corticotropin-releasing hormone (CRH)-containing neurons in the immature rat hippocampal formation: light and electron microscopic features and colocalization with glutamate decarboxylase and parvalbumin. Hippocampus 1998, 8:231-243.
31. Yang G., Zou L.P., Wang J., Ding Y.X. Epigenetic regulation of glucocorticoid receptor and infantile spasms. Med. Hypotheses 2011, 76:187-189.
32. Zou L.P., Zhang W.H., Wang H.M., Zen M., Chen K., Mix E. Maternal IgG suppresses NMDA-induced spasms in infant rats and inhibits NMDA-mediated neurotoxicity in hippocampal neurons. J. Neuroimmunol. 2006, 181:106-111.